Antithrombin III in Patients with Hepatocellular Carcinoma

• References

• 1 Aurousseau MH, D’Angeli JL, Josso F. Antithrombin III versus prothrombin in liver cirrhosis. Haemostasis 1981; 10: 104-107
• 2 Chan V, Lai CL, Chan TK. Metabolism of antithrombin III in cirrhosis and carcinoma of the liver. Clin Science 1981; 60: 681-688
• 3 Boneu B, Sie P, Caranobe C, Cassigneul J, Pascal J. Progressive antithrombin activity and the concentration of three inhibitors in liver cirrhosis. Thromb Haemostas 1982; 47: 78
• 4 Knot E, ten Cate JW, Drijfhout HR, Kahle LH, Tytgat GN. Antithrombin III metabolism in patients with liver disease. J Clin Pathol 1984; 37: 523-530
• 5 Rodzynek J JR, Preux C, Leautaud P, Abramovici J, Di Paolo A, Delcourt AA. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease. Arch Intern Med 1986; 146: 677-680
• 6 Leone G, Cotumaccio R, De Stefano V, Zanetti L, Bizzi B. Different forms of AT III congenital defect: a study by crossed immunoelec-trofocusing. Scand J Haematol 1984; 33: 410-417
• 7 Fair DS, Bahnak BR. Human hepatoma cells secrete single chain Factor X, Prothrombin, and Antithrombin ill. Blood 1984; 64: 194-204